Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qiwei Huiyang Decoction is a traditional Chinese medicine (TCM) herbal preparation being evaluated for the treatment of organ injury following hemorrhagic shock. The formula is traditionally used to restore Yang and rescue patients from collapse, a state analogous to clinical shock. In modern clinical research, particularly at Wuxi No.9 People’s Hospital, it is being studied for its ability to mitigate multiple organ dysfunction syndrome (MODS) by potentially regulating inflammatory cytokines and reducing oxidative stress induced by ischemia-reperfusion. The decoction typically consists of seven primary herbal ingredients, including Ginseng and Prepared Aconite, which are thought to work synergistically to stabilize hemodynamics and protect vital organ function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qiwei Huiyang Decoction.